Serum endocan and endothelial dysfunction in childhood acute lymphoblastic leukemia survivors: a tertiary center experience

Background: An increased risk of cardiovascular complications is reported in survivors of childhood acute lymphoblastic leukemia (ALL). Early identification of impaired vascular health may allow for early interventions to improve outcomes. Aim: The study was conducted to assess the endothelial dysfu...

Full description

Bibliographic Details
Main Authors: Laila M. Sherief, Elhamy R. Abd El-khalek, Ibrahim A. Libda, Osama A. Gaber, Naglaa M. Kamal, Basma K. Soliman, Wesam A. Mokhtar, Ghada A. Mokhtar, Hosam E. Salah, Gehad M. Kamar, Marwa Zakaria
Format: Article
Language:English
Published: SAGE Publishing 2021-05-01
Series:Therapeutic Advances in Chronic Disease
Online Access:https://doi.org/10.1177/20406223211015963
_version_ 1819135977964175360
author Laila M. Sherief
Elhamy R. Abd El-khalek
Ibrahim A. Libda
Osama A. Gaber
Naglaa M. Kamal
Basma K. Soliman
Wesam A. Mokhtar
Ghada A. Mokhtar
Hosam E. Salah
Gehad M. Kamar
Marwa Zakaria
author_facet Laila M. Sherief
Elhamy R. Abd El-khalek
Ibrahim A. Libda
Osama A. Gaber
Naglaa M. Kamal
Basma K. Soliman
Wesam A. Mokhtar
Ghada A. Mokhtar
Hosam E. Salah
Gehad M. Kamar
Marwa Zakaria
author_sort Laila M. Sherief
collection DOAJ
description Background: An increased risk of cardiovascular complications is reported in survivors of childhood acute lymphoblastic leukemia (ALL). Early identification of impaired vascular health may allow for early interventions to improve outcomes. Aim: The study was conducted to assess the endothelial dysfunction in ALL survivors using a new marker, serum endocan, and measurement of the mean common carotid arteries intima media thickness (cIMT). Methods: A case-control study was conducted on 100 childhood ALL survivors (aged 6–18 years), with 80 healthy age and sex-matched children as a control group. Lipid profile, hepatitis markers, and serum ferritin where measured, in addition to the measurement of serum endocan. and cIMT by B-mode high-resolution ultrasonography for all study participants. Results: Triglycerides, total cholesterol, post prandial glucose, and serum ferritin were significantly higher in ALL survivors than controls ( p  < 0.05). Dyslipidemia was detected in 6% of ALL survivors. ALL survivors showed statistically higher serum endocan levels (470.41 ± 556.1 ng/l, versus , 225.94 ± 185.2 ng/l, respectively) and increased cIMT levels compared with the control group (0.650 ± 0.129 mm versus 0.320 ± 0.095 mm, respectively) p  < 0.05. Serum endocan was positively correlated with cIMT and blood cholesterol. Conclusions: The survivors of childhood ALL demonstrated an elevated level of serum endocan and increased cIMT. These can be used as predictors of endothelial dysfunction, and, as a consequence, the risk of developing premature atherosclerosis.
first_indexed 2024-12-22T10:27:40Z
format Article
id doaj.art-b423f1d3829545d1976e04e9896dba96
institution Directory Open Access Journal
issn 2040-6231
language English
last_indexed 2024-12-22T10:27:40Z
publishDate 2021-05-01
publisher SAGE Publishing
record_format Article
series Therapeutic Advances in Chronic Disease
spelling doaj.art-b423f1d3829545d1976e04e9896dba962022-12-21T18:29:26ZengSAGE PublishingTherapeutic Advances in Chronic Disease2040-62312021-05-011210.1177/20406223211015963Serum endocan and endothelial dysfunction in childhood acute lymphoblastic leukemia survivors: a tertiary center experienceLaila M. SheriefElhamy R. Abd El-khalekIbrahim A. LibdaOsama A. GaberNaglaa M. KamalBasma K. SolimanWesam A. MokhtarGhada A. MokhtarHosam E. SalahGehad M. KamarMarwa ZakariaBackground: An increased risk of cardiovascular complications is reported in survivors of childhood acute lymphoblastic leukemia (ALL). Early identification of impaired vascular health may allow for early interventions to improve outcomes. Aim: The study was conducted to assess the endothelial dysfunction in ALL survivors using a new marker, serum endocan, and measurement of the mean common carotid arteries intima media thickness (cIMT). Methods: A case-control study was conducted on 100 childhood ALL survivors (aged 6–18 years), with 80 healthy age and sex-matched children as a control group. Lipid profile, hepatitis markers, and serum ferritin where measured, in addition to the measurement of serum endocan. and cIMT by B-mode high-resolution ultrasonography for all study participants. Results: Triglycerides, total cholesterol, post prandial glucose, and serum ferritin were significantly higher in ALL survivors than controls ( p  < 0.05). Dyslipidemia was detected in 6% of ALL survivors. ALL survivors showed statistically higher serum endocan levels (470.41 ± 556.1 ng/l, versus , 225.94 ± 185.2 ng/l, respectively) and increased cIMT levels compared with the control group (0.650 ± 0.129 mm versus 0.320 ± 0.095 mm, respectively) p  < 0.05. Serum endocan was positively correlated with cIMT and blood cholesterol. Conclusions: The survivors of childhood ALL demonstrated an elevated level of serum endocan and increased cIMT. These can be used as predictors of endothelial dysfunction, and, as a consequence, the risk of developing premature atherosclerosis.https://doi.org/10.1177/20406223211015963
spellingShingle Laila M. Sherief
Elhamy R. Abd El-khalek
Ibrahim A. Libda
Osama A. Gaber
Naglaa M. Kamal
Basma K. Soliman
Wesam A. Mokhtar
Ghada A. Mokhtar
Hosam E. Salah
Gehad M. Kamar
Marwa Zakaria
Serum endocan and endothelial dysfunction in childhood acute lymphoblastic leukemia survivors: a tertiary center experience
Therapeutic Advances in Chronic Disease
title Serum endocan and endothelial dysfunction in childhood acute lymphoblastic leukemia survivors: a tertiary center experience
title_full Serum endocan and endothelial dysfunction in childhood acute lymphoblastic leukemia survivors: a tertiary center experience
title_fullStr Serum endocan and endothelial dysfunction in childhood acute lymphoblastic leukemia survivors: a tertiary center experience
title_full_unstemmed Serum endocan and endothelial dysfunction in childhood acute lymphoblastic leukemia survivors: a tertiary center experience
title_short Serum endocan and endothelial dysfunction in childhood acute lymphoblastic leukemia survivors: a tertiary center experience
title_sort serum endocan and endothelial dysfunction in childhood acute lymphoblastic leukemia survivors a tertiary center experience
url https://doi.org/10.1177/20406223211015963
work_keys_str_mv AT lailamsherief serumendocanandendothelialdysfunctioninchildhoodacutelymphoblasticleukemiasurvivorsatertiarycenterexperience
AT elhamyrabdelkhalek serumendocanandendothelialdysfunctioninchildhoodacutelymphoblasticleukemiasurvivorsatertiarycenterexperience
AT ibrahimalibda serumendocanandendothelialdysfunctioninchildhoodacutelymphoblasticleukemiasurvivorsatertiarycenterexperience
AT osamaagaber serumendocanandendothelialdysfunctioninchildhoodacutelymphoblasticleukemiasurvivorsatertiarycenterexperience
AT naglaamkamal serumendocanandendothelialdysfunctioninchildhoodacutelymphoblasticleukemiasurvivorsatertiarycenterexperience
AT basmaksoliman serumendocanandendothelialdysfunctioninchildhoodacutelymphoblasticleukemiasurvivorsatertiarycenterexperience
AT wesamamokhtar serumendocanandendothelialdysfunctioninchildhoodacutelymphoblasticleukemiasurvivorsatertiarycenterexperience
AT ghadaamokhtar serumendocanandendothelialdysfunctioninchildhoodacutelymphoblasticleukemiasurvivorsatertiarycenterexperience
AT hosamesalah serumendocanandendothelialdysfunctioninchildhoodacutelymphoblasticleukemiasurvivorsatertiarycenterexperience
AT gehadmkamar serumendocanandendothelialdysfunctioninchildhoodacutelymphoblasticleukemiasurvivorsatertiarycenterexperience
AT marwazakaria serumendocanandendothelialdysfunctioninchildhoodacutelymphoblasticleukemiasurvivorsatertiarycenterexperience